123 related articles for article (PubMed ID: 32462905)
21. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
Hu G; Liu G; Ma JY; Hu RJ
Clin Chim Acta; 2018 Nov; 486():44-48. PubMed ID: 30028962
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis.
Jiang KY; Huang H; Chen WY; Yan HJ; Wei ZT; Wang XW; Li HX; Zheng XY; Tian D
World J Gastroenterol; 2021 Feb; 27(8):737-750. PubMed ID: 33716451
[TBL] [Abstract][Full Text] [Related]
23. FOXA1 and CK7 expression in esophageal squamous cell carcinoma and its prognostic significance.
Xu Y; Wang W; Li L; Liu J; Wu X; Yu J; Wang H; Cui W; Zhang R
Neoplasma; 2018 Mar; 65(3):469-476. PubMed ID: 29788741
[TBL] [Abstract][Full Text] [Related]
24. Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma.
Wang J; Liu Z; Wang Z; Wang S; Chen Z; Li Z; Zhang M; Zou J; Dong B; Gao J; Shen L
Cancer Lett; 2018 Apr; 419():64-74. PubMed ID: 29366803
[TBL] [Abstract][Full Text] [Related]
25. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Qu HX; Zhao LP; Zhan SH; Geng CX; Xu L; Xin YN; Jiang XJ
J Thorac Dis; 2016 Nov; 8(11):3197-3204. PubMed ID: 28066599
[TBL] [Abstract][Full Text] [Related]
27. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
28. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.
Cui XB; Peng H; Li S; Li TT; Liu CX; Zhang SM; Jin TT; Hu JM; Jiang JF; Liang WH; Li N; Li L; Chen YZ; Li F
Asian Pac J Cancer Prev; 2014; 15(22):9661-6. PubMed ID: 25520085
[TBL] [Abstract][Full Text] [Related]
30. SIRT1 Expression Is a Promising Prognostic Biomarker in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Otsuka R; Sakata H; Murakami K; Kano M; Endo S; Toyozumi T; Matsumoto Y; Suito H; Takahashi M; Sekino N; Hirasawa S; Kinoshita K; Sasaki T; Matsubara H
Cancer Diagn Progn; 2022; 2(2):126-133. PubMed ID: 35399170
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic role of MMP-9 in esophageal squamous cell carcinoma: a meta-analysis.
Zeng R; Duan L; Kong Y; Liang Y; Wu X; Wei X; Yang K
Chin J Cancer Res; 2013 Dec; 25(6):637-45. PubMed ID: 24385690
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
33. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma.
Yang X; Lu Q; Xu Y; Liu C; Sun Q
Pathol Res Pract; 2020 Jan; 216(1):152787. PubMed ID: 31859114
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
36. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.
Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R
Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349
[TBL] [Abstract][Full Text] [Related]
37. The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis.
Wang P; Xu L; Li L; Ren S; Tang J; Zhang M; Xu M
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):957-968. PubMed ID: 30747316
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
39. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
40. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
